"
Low Doses of Rifampicin Used in New Tuberculosis Patients Correlated to Increased Frequency of Rifampicin-Resistance and Poorer Treatment Outcomes"
written by Ling Chen, Jian Du, Liang Li, Qi Li, Qiu Zhong, Yanyong Fu, Bo Li, Minggui Lin, Liping Ma, Youlun Li, Xiaomeng Wang, Yan Ma, Xiaoying Jiang, Xiaoyou Chen, Qiping Ge, Li Xie, Xiqin Han, Zhaogang Sun, Guanglu Jiang, Hong Zhang, Weiwei Gao,
published by
Open Journal of Medical Microbiology,
Vol.5 No.2, 2015
has been cited by the following article(s):
|
[1]
|
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
BMC Infectious Diseases,
2024
DOI:10.1186/s12879-023-08909-2
|
|
|
|